Fyavolv Tablet, Film Coated
Product Images NDC 68180-827

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Fyavolv (NDC 68180-827). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 01

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 02

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 03

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 04

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 05

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 06

This is a figure depicting the mean percent change from baseline in volumetric bone mineral density at the lumbar spine, as measured by quantitative computed tomography after 12 and 24 months of treatment in the intent-to-treat population. Three treatments are compared: placebo, a combination of norethindrone acetate and ethinyl estradiol 0.5/2.5, and a combination of norethindrone acetate and ethinyl estradiol 1/5. The SE is also displayed. The p-value of the comparison between treatment and placebo is less than 0.001.*

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 07

Fyavolv is a medication that contains oretrincrone acetate and ethinyl estradiol. This is a non-child-resistant package, and you must keep it away from children. The medication should be stored at a temperature of 25°C (77°F) and excursions permitted at 15-30°C (59-86°F). The medication is distributed by Lupin Pharmaceuticals and Lupin Limited from Baltimore, Maryland. The NDC for the medication is 68120-827-11, and the lot number is 282010.*

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 08

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 09

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 10

Fyavolv™ is a prescription medication that contains norethindrone acetate and ethinyl estradiol in tablet form. Each tablet contains 0.5 mg of norethindrone acetate USP and 0.0025 mg of ethinyl estradiol USP. The usual dosage is one tablet daily, and patient information should be dispensed with each prescription. The medication should be stored at 25°C (77°F), with excursions permitted to 15 to 30°C (59 to 86°F). Fyavolv™ is distributed by Lupin Pharmaceuticals, Inc. in Baltimore, Maryland, and manufactured by Lupin Limited in India. Patients should keep the medication out of reach of children and can report any suspected adverse reactions to Lupin Pharmaceuticals, Inc. or through the FDA's MedWatch program.*

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 11

Fyavolv is a combination drug consisting of Porethindione acetate and Ethinyl estradiol. It comes in a 1mg/0.005mg packaging, that is not child resistant, and hence should be kept out of children's reach. The drug should be stored at a temperature of 25C (77°F), and conventional manipulations permit 150 30 (591086 [s22 USP Contolled Room Temperature). The manufacturer is Lupin Limited, located in Baltimore, Maryland. The rest of the text is not-available.*

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 12

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 13

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 14

This text describes a medication with the NDC number 68180-828-09. It is a combination of norethindrone acetate and ethinyl estradiol tablets, with each blue film-coated tablet containing 1mg of norethindrone acetate USP and 0.005mg of ethinyl estradiol USP. It is manufactured by Lupin Pharmaceuticals, Inc. and distributed in the United States. The text advises keeping the medication out of reach of children and includes a contact number for reporting suspected adverse reactions. Storage instructions are also included. The medication is only available by prescription and should include patient information with each prescription dispensed by a pharmacist.*

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 15

This text seems to be a label for a medicine called "norethindrone acetate and ethinyl estradiol tablets USP". The label includes information regarding the ingredients, dosage, storage, and distribution of the medicine. It is manufactured by Lupin Limited and distributed by Lupin Pharmaceuticals, Inc. The lot number is EXR=265111, and the label indicates a manufacturing date of June 26th, 2010. Store the medicine at 25°C (77°F), with excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].*

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 16

Fyavolv is a prescription-only medication which comes in a blister pack of 28 tablets. Each tablet contains 0.5 mg of norethindrone acetate and 0.0025 mg of ethinyl estradiol. The National Drug Code for this medication is 68180-827-71.*

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 17

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 18

This is a description of medication called Fyavolv produced by Lupin Limited in India and distributed by Lupin Pharmaceuticals in the US. The tablets contain norethindrone acetate and ethinyl estradiol, and the dosage is 1 mg/0.005 mg. The recommended storage temperature is 25°C with permitted excursions to 15-30°C. The lot number is 82871.*

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 19

This is a description of a prescription drug called FyavolvTM. It comes in the form of 28 tablets in a pack, with each tablet containing 1mg of norethindrone acetate and 0.005mg of ethinyl estradiol. It is only available with a doctor's prescription.*

FDA Label Image

4ee645be 2e7e 480e 8714 B2466a408b4b 20

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.